Bowron Kimberly T sold $16K of GEVO

Bowron Kimberly T (Chief of Staff) sold 10,257 shares of Gevo, Inc. (GEVO) at $1.55 on 2026-08-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bowron Kimberly T
Published Aug 7, 2026, 9:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GEVO
Neutral
medium confidence
Mentioned
$GEVO
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GEVONeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may influence short-term sentiment, but it does not introduce new operational, regulatory, or financial information about Gevo.

02

Market read

Traders may note the insider sale for sentiment monitoring, but there is no new fundamental catalyst in the text.

03

What to watch

The article does not state whether the sale was part of a larger scheduled program cadence, nor does it provide options/other transactions that could offset the sale.

Relevance 2/10Novelty 3/10Timing: filed 2026-08-07 after-hours; sale dated 2026-08-06

Background

This is an SEC Form 4 insider transaction disclosure for Gevo, Inc., reported by Bowron Kimberly T (Chief of Staff) as an open-market sale under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$GEVONeutralMedium confidence
Context

Gevo insider Bowron Kimberly T sold 10,257 shares in an open-market transaction at $1.5458 on 2026-08-06 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a Form 4 insider sale with a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling. The article contains no new company-specific operational or financial catalyst.

Market effects

Minimal; insider sale in a single small-cap does not materially change sector fundamentals.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be read as caution about near-term risk, especially in thinly traded names.

Key entities

  • Gevo, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Bowron Kimberly T

    Chief of Staff who sold 10,257 shares at $1.5458 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GEVOHigh

Why is Gevo stock rocketing higher today

Gevo (NASDAQ:GEVO) shares surged 35.7% after reporting Q3 2026 results with revenue up 94.2% YoY to $82.95M, beating estimates. GAAP profit was $0.09 per share. The company cited strong earnings power and growth plans in sustainable aviation fuel and technology licensing. Shares are volatile, down 7.7% YTD, and 31.5% below 52-week high.

$GEVOHigh

Why Gevo Stock Rocketed Higher Today

Gevo (GEVO) shares rose 30.9% to $1.82 after reporting Q3 2026 revenue of $83M, up 94% YoY, and adjusted EPS of $0.12, beating estimates. The company also raised its 2026 adjusted EBITDA forecast to $90M from $60M, driven by its carbon business.

$GEVOHigh

Gevo Reports Record Third Quarter 2026 Financial Results

Gevo, Inc. (GEVO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Gevo Reports Record Third Quarter 2026 Financial Results Gevo Carbon Business Drives Net Income of $23 million and Adjusted EBITDA 1 of $44 million for Third Quarter ENGLEWOOD, Colo. – November 10, 2026 – Gevo, Inc. (NASDAQ: GEVO) today announced its financial result